The additional study results were presented in an oral presentation session at the 2025 San Antonio Breast Cancer Symposium (“SABCS”) today, Thursday, ...
News
- Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase ... - StreetInsider
- Wobble Genomics To Present New Data At SABCS Confirming Platform's Ability To ... - Morningstar
EDINBURGH, Scotland, Dec. 11, 2025 /PRNewswire/ -- Wobble Genomics, a biotechnology ... San Antonio, Texas. The data demonstrates the ability to ...
- Roche's Oral SERD Cuts Death Risk by 30% in Early-Stage Breast Cancer - BioSpace
Roche presented these findings at the 2025 San Antonio Breast Cancer Symposium (SABCS). ... biotech and science. He can be reached at tristan ...
- Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a ...
... San Antonio Breast Cancer Symposium. Business Wire; Dec 11, 2025; 7 mins ... (“Avenzo”), a clinical-stage biotechnology company developing next ...
- 'Are you married?' Why doctors ask invasive questions during treatment
(THE CONVERSATION) It's a rare occasion when my worlds of biomedical informatics and serialized lesbian melodrama fandom collide. ... San Antonio-based ...